Although MGMT promoter hypermethylation in GBM tumors is clinically associated with a better initial TMZ treatment response (Hegi et al., 2005), even MGMT‐negative GBM cells do not sufficiently respond to TMZ. Here, MGMT is linked to glioblastoma.